Precigen (PGEN) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free PGEN Stock Alerts $1.40 +0.07 (+5.26%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 24, 2024 | americanbankingnews.comTerns Pharmaceuticals (NASDAQ:TERN) and Precigen (NASDAQ:PGEN) Head to Head SurveyMay 23, 2024 | prnewswire.comPrecigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual MeetingMay 17, 2024 | marketbeat.comCantor Fitzgerald Research Analysts Decrease Earnings Estimates for Precigen, Inc. (NASDAQ:PGEN)Precigen, Inc. (NASDAQ:PGEN - Free Report) - Cantor Fitzgerald dropped their FY2024 earnings estimates for shares of Precigen in a report released on Wednesday, May 15th. Cantor Fitzgerald analyst J. Kim now expects that the biotechnology company will post earnings of ($0.36) per share for the yeMay 16, 2024 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Forecasted to Post FY2028 Earnings of $0.62 Per SharePrecigen, Inc. (NASDAQ:PGEN - Free Report) - Stock analysts at HC Wainwright lowered their FY2028 earnings estimates for Precigen in a research report issued on Wednesday, May 15th. HC Wainwright analyst S. Ramakanth now forecasts that the biotechnology company will post earnings per share of $0.May 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Precigen Amid Promising Clinical Data and Strong Financial OutlookMay 15, 2024 | marketbeat.comPrecigen (NASDAQ:PGEN) Issues Earnings Results, Misses Expectations By $0.01 EPSPrecigen (NASDAQ:PGEN - Get Free Report) released its quarterly earnings results on Tuesday. The biotechnology company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.09) by ($0.01). Precigen had a negative net margin of 1,540.63% and a negative return on equity of 55.47%. The company had revenue of $1.07 million during the quarter, compared to the consensus estimate of $1.54 million. During the same quarter last year, the firm posted ($0.10) EPS.May 15, 2024 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the four brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and three have given a buy rating tMay 15, 2024 | marketbeat.comPrecigen (NASDAQ:PGEN) Earns "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Precigen in a report on Wednesday.May 15, 2024 | finanznachrichten.dePrecigen, Inc.: Precigen Reports First Quarter 2024 Financial Results and Business UpdatesMay 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Precigen Amid Promising Clinical Developments and Strategic FDA AlignmentMay 14, 2024 | investorplace.comPGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | prnewswire.comPrecigen Reports First Quarter 2024 Financial Results and Business UpdatesMay 14, 2024 | markets.businessinsider.comHere's what to expect from Precigen's earnings reportMay 14, 2024 | msn.comStocks Mixed as US PPI Report Signals Sticky Price PressuresMay 14, 2024 | theglobeandmail.comStock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell RemarksMay 13, 2024 | msn.comPrecigen Q1 2024 Earnings PreviewMay 9, 2024 | marketbeat.comPrecigen (PGEN) Scheduled to Post Earnings on TuesdayPrecigen (NASDAQ:PGEN) will be releasing earnings after the market closes on Tuesday, May 14, Zacks reports.May 8, 2024 | prnewswire.comPrecigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual MeetingApril 26, 2024 | finanznachrichten.deActym Therapeutics Inc.: Actym Therapeutics Appoints Thomas Smart as CEOApril 24, 2024 | prnewswire.comPrecigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual MeetingApril 24, 2024 | prnewswire.comActym Therapeutics Appoints Thomas Smart as CEOMarch 28, 2024 | prnewswire.comPrecigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11thMarch 26, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN), Cronos Group (CRON) and Marinus (MRNS)March 22, 2024 | msn.comJ.P. Morgan cuts Precigen to underweight, cites burn rateMarch 22, 2024 | marketbeat.comPrecigen (NASDAQ:PGEN) Downgraded by JPMorgan Chase & Co. to UnderweightJPMorgan Chase & Co. cut shares of Precigen from a "neutral" rating to an "underweight" rating in a report on Friday.March 22, 2024 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) to Post Q1 2024 Earnings of ($0.09) Per Share, HC Wainwright ForecastsPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Equities research analysts at HC Wainwright cut their Q1 2024 earnings per share (EPS) estimates for Precigen in a note issued to investors on Wednesday, March 20th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company willMarch 21, 2024 | bizjournals.comGermantown biotech expands manufacturing capacity, headcount ahead of potential product launchMarch 20, 2024 | markets.businessinsider.comBuy Rating Affirmed on Precigen Amid Promising PRGN-2012 Clinical Progress and Financial StabilityMarch 20, 2024 | finance.yahoo.comPrecigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | marketbeat.comPrecigen's (PGEN) "Market Outperform" Rating Reaffirmed at JMP SecuritiesJMP Securities reaffirmed a "market outperform" rating and set a $14.00 target price on shares of Precigen in a research note on Wednesday.March 20, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Taysha Gene Therapies (TSHA)March 19, 2024 | seekingalpha.comPrecigen, Inc. (PGEN) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | investorplace.comPGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023March 19, 2024 | finance.yahoo.comPrecigen Inc (PGEN) Reports Full Year 2023 Financial ResultsMarch 19, 2024 | benzinga.comRecap: Precigen Q4 EarningsMarch 19, 2024 | finance.yahoo.comPrecigen Reports Full Year 2023 Financial Results and Business UpdatesMarch 19, 2024 | msn.comUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatMarch 18, 2024 | benzinga.comPreview: Precigen's EarningsMarch 14, 2024 | msn.comAnika Therapeutics to reduce workforce by 9%March 12, 2024 | finance.yahoo.comPrecigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory PapillomatosisMarch 8, 2024 | finance.yahoo.comPrecigen, Inc.'s (NASDAQ:PGEN) top owners are private equity firms with 38% stake, while 30% is held by institutionsMarch 5, 2024 | prnewswire.comPrecigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19thFebruary 20, 2024 | finance.yahoo.comPrecigen, Inc. (NASDAQ:PGEN): When Will It Breakeven?February 15, 2024 | finance.yahoo.comPGEN Mar 2024 1.500 callFebruary 15, 2024 | finance.yahoo.comPGEN Jul 2024 1.500 callFebruary 15, 2024 | finance.yahoo.comPGEN Jul 2024 2.500 putFebruary 15, 2024 | finance.yahoo.comPGEN Jul 2024 0.500 callFebruary 9, 2024 | msn.comPrecigen Finalizes Executive Severance AgreementsFebruary 6, 2024 | finance.yahoo.comPrecigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceFebruary 4, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$1.72m On Precigen Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Gates is all about this tiny $2 stock (Ad)What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock… >>Click here to discover why Bill Gates is all about this tiny $2 stock. PGEN Media Mentions By Week PGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼1.870.77▲Average Medical News Sentiment PGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼12▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FBLG News Today ANRO News Today SKYE News Today NBTX News Today ORGO News Today VTYX News Today AMRN News Today ACIU News Today VRCA News Today NKTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
